You are not connected. The newsletter may include some user information, so they may not be displayed correctly.

ASCIA Update 23 April 2024

ASCIA Update 23 April 2024

‍‍ ‍ ‍ ‍Click here to view it online

ASCIA Update

23 April 2024

--- 

New Quicklinks Webpage with QR Codes to ASCIA information

ASCIA Quicklinks include QR codes that link to information for patients and carers about anaphylaxis, allergy and other immune system disorders.

ASCIA Quicklinks can be printed out as A4 documents or posters and are available open access on a new ASCIA Quicklinks webpage

This work has been completed as part of the National Allergy Council Shared Care for Allergy project.

-- 

Updated ASCIA Immunodeficiency Patient and Carer Information

To coincide with World Primary Immunodeficiency (PI) Week (22-28 April 2024) and the International Day of Immunology (29 April 2024), ASCIA information for patients and carers about primary immunodeficiencies (also known as inborn errors of immunity) has been updated to make it easier to:

  • Read and understand, by simplifying language and changing to FAQ formats.
  • Contact support organisations by including links to their websites at the start of each FAQ.

SCIg Therapy - General Information has been updated to include subcutaneous immunoglobulin (SCIg) products that are currently available in Australia and New Zealand. This FAQ is not specific for immunology and can be used by any patients/carers who need general information about SCIg, including management guides for SCIg infusion site reactions, problems and other reactions.

-- 

New Mast Cell Activation Disorders and Syndrome Position Paper

A new ASCIA Position Paper on the diagnosis and investigation of mast cell activation disorders and syndrome has been developed for health professionals.

Mast cell activation syndrome is a group of disorders with episodic symptoms due to mast cell mediator release. They involve multiple systems and can cause flushing, pruritus, wheeze and gastrointestinal symptoms.

Diagnosis is based on clinical and laboratory assessments, including testing for tryptase. Other laboratory tests are generally not used or available, due to their lack of sensitivity and specificity.

ASCIA Mastocytosis and other Mast Cell Disorders FAQ for patients and carers is also available.

 --

Updated ASCIA Allergy Patient and Carer Information

The latest ASCIA patient/carer allergy information topic areas to be updated are:

The updates are being made by the ASCIA team as part of the National Allergy Council Shared Care for Allergy project, to make it easier to:

  • Read and understand, by simplifying language and changing to FAQ formats.
  • Contact support organisations by including links to their websites at the start of each FAQ.

Previous topic areas that have been updated are:

--

EOIs for Allergy Education and Training - Due 8 May 2024

Due to several holidays occurring during April, the due date for EOIs has been extended by two weeks, to 8 May 2024 and the form is on the ASCIA website 

ASCIA is facilitating education and training initiatives to upskill health professionals, as part of the National Allergy Council Shared Care for Allergy project.

ASCIA is now inviting Expressions of Interests (EOI) from ASCIA members for funding of initiatives that provide standardised, evidence-based and best practice postgraduate allergy education and training for health professionals, including those in regional, rural and remote areas.

-- 

EOIs for AIFA Research Grants - Due 14 May 2024

ASCIA members, including early career and new researchers, are invited to submit expressions of interest (EOI) for Allergy and Immunology Foundation of Australasia (AIFA) research grants.

Thank you to supporters of AIFA research grants, who have enabled a total of $110,000 to be awarded in 2024, comprised of 8 grants:

  • $40,000 AIFA Early Career and New Researcher Grants (4 x $10,000)
  • $20,000 AIFA Prof Ann Kupa Food Allergy Grant
  • $15,000 AIFA DBV Technologies Food Allergy Grant
  • $20,000 AIFA Viatris Nurse Researcher of the Year
  • $15,000 AIFA CSL Behring HAE Clinical Research Grant

EOIs are due by 14 May 2024 and the form is on the AIFA website

Donate here to support AIFA’s 2025 research grants.

--

Meetings 2024

Registration is still open for the following meetings:

Registration will open in May 2024 for the:

ASCIA 2024 Conference 3-6 September

Save the date for the:

ANZAAG (Australian and New Zealand Anaesthetic Allergy Group) and ISPAR (International Suspected Perioperative Allergic Reaction Group) Symposium 15-17 November, Melbourne

 

Other meetings are listed in the ASCIA website conference calendar

--

Regularly Updated ASCIA Webpages

The following ASCIA webpages are regularly updated:

ASCIA Reports

Locate a Specialist

ASCIA Submissions

Allergy/Immunology Positions

Medical Product Supply Updates

Allergy and Immunology Research

Conference, Meetings and Events Calendar

 

ASCIA gratefully acknowledges the generous support of all sponsors listed on the ASCIA website www.allergy.org.au/about-ascia/sponsors



ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand.  

ASCIA Updates provide current information to the community about allergy and other immune system disorders.

AIFA

AIFA is dedicated to improving the health of people with allergy and other immune system disorders by providing AIFA allergy and immunology research grants. 

ASCIA Conference

facebookxlinkedin

‍‍ ‍ ‍ ‍ ‍ ‍Unsubscribe to ASCIA Update